Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
<p>Abstract</p> <p>Background</p> <p>Expression of c-myc proto-oncogene is inappropriate in a wide range of human tumors, and is a downstream target of Ras/Raf/ERK pathway, which promotes c-Myc stability by enhancing c-Myc expression and activity.</p> <p>The...
Main Authors: | Ciccarelli Carmela, Marampon Francesco, Zani Bianca M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-08-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/5/1/31 |
Similar Items
-
Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation
by: Francesco Marampon, et al.
Published: (2019-05-01) -
p21<sup>WAF1 </sup>expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells
by: Giacinti Cristina, et al.
Published: (2005-12-01) -
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma
by: Benedetti, A., et al.
Published: (2022) -
IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway
by: Jing Chu, et al.
Published: (2019-01-01) -
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
by: Rakshamani Tripathi, et al.
Published: (2020-10-01)